Antares Pharma (Antares Pharma) Days Inventory : 56.24 (As of Mar. 2022)

View and export this data going back to 1996. Start your Free Trial

What is Antares Pharma Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Antares Pharma's Average Total Inventories for the three months ended in Mar. 2022 was $11.6 Mil. Antares Pharma's Cost of Goods Sold for the three months ended in Mar. 2022 was $18.8 Mil. Hence, Antares Pharma's Days Inventory for the three months ended in Mar. 2022 was 56.24.

The historical rank and industry rank for Antares Pharma's Days Inventory or its related term are showing as below:

ATRS' s Days Inventory Range Over the Past 10 Years
Min: 36.33 Med: 98.93 Max: 200.11
Current: 80.53

During the past 13 years, Antares Pharma's highest Days Inventory was 200.11. The lowest was 36.33. And the median was 98.93.

ATRS's Days Inventory is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 186.925 vs ATRS: 80.53

Antares Pharma's Days Inventory declined from Mar. 2021 (104.96) to Mar. 2022 (56.24).

Inventory Turnover measures how fast the company turns over its inventory within a year. Antares Pharma's Inventory Turnover for the three months ended in Mar. 2022 was 1.62.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Antares Pharma's Inventory-to-Revenue for the three months ended in Mar. 2022 was 0.28.

Antares Pharma Days Inventory Historical Data

The historical data trend for Antares Pharma's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antares Pharma Days Inventory Chart

Antares Pharma Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Days Inventory

Get a 7-Day Free Trial

97.02

121.17

98.89

98.96

79.54

Antares Pharma Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Days Inventory	Get a 7-Day Free Trial															104.96	106.18	97.58	67.44	56.24

Competitive Comparison of Antares Pharma's Days Inventory

For the Medical Instruments & Supplies subindustry, Antares Pharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Antares Pharma's Days Inventory Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Antares Pharma's Days Inventory distribution charts can be found below:

* The bar in red indicates where Antares Pharma's Days Inventory falls into.

Antares Pharma Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Antares Pharma's Days Inventory for the fiscal year that ended in Dec. 2021 is calculated as

	Days Inventory (A: Dec. 2021 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2020 )	+	Total Inventories (A: Dec. 2021 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2021 )	*	Days in Period
=	( (18.216	+	11.544)	/	2 )	/	68.281	*	365
=	14.88					/	68.281	*	365
=	79.54

Antares Pharma's Days Inventory for the quarter that ended in Mar. 2022 is calculated as:

	Days Inventory (Q: Mar. 2022 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Dec. 2021 )	+	Total Inventories (Q: Mar. 2022 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2022 )	*	Days in Period
=	( (11.544	+	11.591)	/	2 )	/	18.767	*	365 / 4
=	11.5675					/	18.767	*	365 / 4
=	56.24

Antares Pharma (NAS:ATRS) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Antares Pharma's Inventory Turnover for the three months ended in Mar. 2022 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	18.767	/	11.5675
	=	1.62

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Antares Pharma's Inventory to Revenue for the three months ended in Mar. 2022 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	11.5675	/	41.557
	=	0.28

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Antares Pharma Days Inventory Related Terms

Thank you for viewing the detailed overview of Antares Pharma's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Antares Pharma (Antares Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Antares Pharma Inc (NAS:ATRS) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Princeton South, Suite 300, Ewing, NJ, USA, 08628

Website

https://www.antarespharma.com

Antares Pharma Inc is a specialty pharmaceutical company. It is focused on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. The company's products include OTREXUP, Elestrin, Gelnique, Makena, and others.

Executives

Karen L. Smith	director	C/O JAZZ PHARMACEUTICALS PLC, 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN L2 4 L2
Carmen B Volkart	director	C/O MODULAR MEDICAL, INC., 16772 WEST BERNARDO DRIVE, SAN DIEGO CA 92127
Peter C Richardson	officer: See Remarks	28903 NORTH AVENUE PAINE, VALENCIA CA 91355
Fred M Powell	officer: Executive Vice President & CFO	C/O BEJING MED-PHARM CORPORATION 600 W. GERMANTOWN PIKE, SUITE 400 PLYMOUTH MEETING PA 19462
Thomas J Garrity	director
Roche Robert P Jr	director	41 MOORES ROAD FRAZER PA 19355
Leonard S Jacob	director	C/O INKINE PHARMACEUTICAL COMPANY INC 425 PARK AVENUE NEW YORK NY 10022
Peter J Graham	officer: See Remarks	315 E. 72ND ST., APT 5E, NEW YORK NY 10021
Peter Greenleaf	director	ONE MEDIMMUNE WAY, GAITHERSBURG MD 20878
Anton Gueth	director
Robert F Apple	director, officer: President & CEO	C/O INKLINE PHARMACEUTICAL CO INC SENTRY PARK EAST 1720 WALTON ROAD BLUE BELL PA 19422
Marvin Samson	director
Jacques Gonella	director	C/O ANTARES PHARMA INC 707 EAGLEVIEW BLVD SUITE 414 EXTON PA 19341
James Patrick Tursi	officer: EVP, Chief Medical Officer	106 ASHLEY COURT, MOORESTOWN NJ 08057
Keith E Muckenhirn	officer: VP/Controller & Interim CFO	C/O ANTARES PHARMA, INC. 3905 ANNAPOLIS LANE N, SUITE 105 PLYMOUTH MN 55447